The role of HRECs in regulating medical research: from peer review to regulation

In Australia, Human Research Ethics Committees (HRECs) play a ubiquitous role reviewing human subjects research, as do Institutional Review Boards in the US and elsewhere. While HRECs were established as peer review bodies, we argue they should now be characterised a 'devolved regulator' within the broader context of the regulatory state. We evidence HRECs' regulatory role through three examples of current responsibilities. By categorising HRECs as a regulator, we are able to assess their role through a regulatory lens. Drawing on Reeve and Magnusson's 'regulatory scaffolding' approach, we suggest key ways in which the role provided by HRECs could be improved. These include setting clear roles and responsibilities HREC review; ensuring HREC accountability for the substantive aspects of their decision making; and accountability for trial sponsors who seek review of trials under the Clinical Trials Notification Scheme. Deficits in the above must incur a credible expectation of escalation and review.

Authors

Institutions

Publication Details

Journal
Bioethics News
Published
2025-05-15
DOI
https://doi.org/10.1007/s40592-025-00248-z
Citations
1
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
1.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of HRECs in regulating medical research: from peer review to regulation

Jenny Kaldor, Lisa Eckstein, Cameron Stewart
1 citations
Bioethics News
Ethics in Clinical Research
1.88
article

The role of HRECs in regulating medical research: from peer review to regulation

Jenny Kaldor, Lisa Eckstein, Cameron Stewart
article en
1 citations

Abstract

In Australia, Human Research Ethics Committees (HRECs) play a ubiquitous role reviewing human subjects research, as do Institutional Review Boards in the US and elsewhere. While HRECs were established as peer review bodies, we argue they should now be characterised a 'devolved regulator' within the broader context of the regulatory state. We evidence HRECs' regulatory role through three examples of current responsibilities. By categorising HRECs as a regulator, we are able to assess their role through a regulatory lens. Drawing on Reeve and Magnusson's 'regulatory scaffolding' approach, we suggest key ways in which the role provided by HRECs could be improved. These include setting clear roles and responsibilities HREC review; ensuring HREC accountability for the substantive aspects of their decision making; and accountability for trial sponsors who seek review of trials under the Clinical Trials Notification Scheme. Deficits in the above must incur a credible expectation of escalation and review.

Bioethics NewsVol. 43(1)
The University of Sydney (AU), University of Tasmania (AU), Bell Resources (Australia) (AU), Tasmanian Abalone Council (Australia) (AU)
ACT Government, University of Sydney, Medical Research Council, National Health and Medical Research Council
Peace, Justice and strong institutions
Openalex Percentile: Top 16%
Ethics in Clinical Research
1.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The role of HRECs in regulating medical research: from peer review to regulation — Jenny Kaldor, Lisa Eckstein, et al. · Bioethics News (2025) | TGRS Research Map | TGRS